#United States #New Orleans #Hanmi Pharmaceutical #Countmate #McKesson

Introduction

Hanmi Pharmaceutical has officially launched its new automated vial dispensing solution, Countmate, aimed at enhancing pharmacy operations in Canada and the United States. This innovative system represents a significant step for the company as it seeks to expand its market presence in North America, traditionally dominated by vial-based medication dispensing compared to pouch-style methods typically used in South Korea.

Overview of Countmate

Countmate is a fully automated vial dispensing machine designed to streamline the entire dispensing process. This includes everything from drug counting and dispensing to labeling, image verification, and final vial discharge. Such capabilities are particularly significant as they align with the dispensing practices prevalent in Canada and the US, thereby catering to local pharmacy needs more effectively.

With a capacity to process up to 160 prescriptions per hour, Countmate is geared towards improving efficiency for high-demand pharmacy settings. It incorporates advanced technologies such as multi-front-mounted canisters for automatic drug counting and an orthogonal robot designed for precise labeling. This automated system is a game changer for pharmacy operations, encouraging the adoption of sophisticated technology in a field that is rapidly evolving.

Collaboration with McKesson

In order to facilitate its introduction in the North American market, Hanmi has partnered with McKesson Automation, a prominent distributor in the region. Their collaboration is expected to combine Hanmi's innovative technology with McKesson's extensive knowledge of the market and distribution networks. Countmate was officially showcased at the ASHP (American Society of Health-System Pharmacists) Midyear 2024 Conference, which provided an excellent platform for pharmacists and industry professionals to experience the machine firsthand.

Key Features of Countmate

Countmate includes several features that enhance its operational effectiveness:

• - Comprehensive Automation: The machine automatizes the entire vial preparation process, significantly reducing manual labor and the potential for human error.
• - Advanced Verification: Built-in imaging technology allows for rigorous verification procedures, ensuring that every vial is accurately labeled and safe for dispensing.
• - Customizable Canisters: Pharmacies can choose between configurations of 84 or 168 canisters, allowing them to tailor the machine to their specific size and operational requirements.
• - Safety Measures: Safety sensors are integrated to detect human presence, ensuring that operations can proceed without risk to personnel.
• - Compact Design: Countmate's design is space-efficient, allowing it to fit into various pharmacy layouts without requiring significant changes to the existing setup.

Importance of Market Entry

The launch of Countmate is pivotal for Hanmi as it seeks to solidify its presence in North America. This strategic move highlights the company's commitment to innovating products that not only meet but exceed the expectations of the pharmaceutical market in this region. By introducing technology that aligns closely with local dispensing practices, Hanmi aims to drive growth and increase its share of the North American pharmacy automation market.

Future Aspirations

Hanmi Pharmaceutical is poised for further advancements and expansions beyond the launch of Countmate. Their goal is to continue seeking out innovative opportunities that leverage their technological capabilities in tandem with strong partnerships, notably with McKesson. CEO Park Jae-Hyun has emphasized the need for continued growth and has articulated the vision for Hanmi to enhance its overseas market penetration, ensuring that the company remains competitive on a global scale.

As the pharmaceutical landscape evolves, Countmate is set to play a significant role in redefining how pharmacies operate, paving the way for increased efficiency and improved safety in medication dispensing.

Conclusion

With the introduction of Countmate, Hanmi Pharmaceutical demonstrates its dedication to innovation in the healthcare sector. The combined strengths of advanced technology and strategic partnerships are expected to yield substantial benefits for pharmacies in North America, making this a notable moment in the evolution of pharmaceutical dispensing practices.